iRhythm Technologies Announces Pricing of Initial Public Offering

On October 19, 2016, iRhythm Technologies, a leading digital health care solutions company focused on the advancement of cardiac care, announced the pricing of its initial public offering of 6,294,118 shares of its common stock at a price to the public of $17.00 per share. The company's shares began trading on the Nasdaq Global Select Market on October 20, 2016, under the ticker symbol "IRTC." Wilson Sonsini Goodrich & Rosati is advising iRhythm in the offering.

The company has granted the underwriters a 30-day option to purchase up to an additional 944,117 shares of its common stock to cover overallotments, if any. J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering, while Canaccord Genuity and BTIG are acting as co-managers. The offering is expected to close on October 25, 2016, subject to customary closing conditions.

The WSGR team advising iRhythm in the offering includes partners Philip Oettinger, Calise Cheng, and Scott McCall and associates Jesse Schumaker, Zhimin Yang, Michael Klippert, Myra Sutanto Shen, Matthew Kovac, and Nathan Cao.

For more information, please see iRhythm's press release.